A case of confluent and reticulated papillomatosis that successfully responded to roxithromycin [2]

Journal of Dermatology

Volumn 33, Issue 1, 2006, Pages 71-72

  Ito, Sachie ^a   Hatamochi, Atsushi ^a   Yamazaki, Soji ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLARITHROMYCIN; DOXYCYCLINE; ERYTHROMYCIN; FUSIDIC ACID; MACROLIDE; MINOCYCLINE; ROXITHROMYCIN; TETRACYCLINE DERIVATIVE;

ADULT; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; BODY MASS; CASE REPORT; CELL PROLIFERATION; CONFLUENT AND RETICULATED PAPILLOMATOSIS; DIAGNOSTIC PROCEDURE; EPIDERMIS; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; LETTER; MALE; MEDICAL EXAMINATION; PHYSICAL EXAMINATION; SKIN BIOPSY; SKIN PIGMENTATION;

ADMINISTRATION, ORAL; ADULT; ANTI-BACTERIAL AGENTS; BACK; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; PAPILLOMA; ROXITHROMYCIN; SKIN NEOPLASMS; THORAX;

EID: 33645225288     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2006.00015.x     Document Type: Letter

References (10)

1. Gougerot H Carteaud A. Papillomatose pigmentee innominee. Bull Soc Fr Dermatol Syphiligr 1927 34 719 721.
2. Shimizu S Han-Yak H. Confluent and reticulated papillomatosis responsive to minocycline. Dermatology 1997 194 59 61.
3. Humbert P Treffel P Chapuis JF Buchet S Derancourt C Agache P. The tetracyclines in dermatology. J Am Acad Dermatol 1991 25 691 697.
4. Angeli-Besson C Koeppel MC Jacquet P Andrac L Sayag J. Confluent and reticulated papillomatosis (Gougerot-Carteaud) treated with tetracyclines. Int J Dermatol 1995 34 567 569.
5. Jang HS Oh CK Cha JH Cho SH Kwon KS. Six cases of confluent and reticulated papillomatosis alleviated by various antibiotics. J Am Acad Dermatol 2001 44 652 655.
6. Komatsu T Ishimaru S Yamamoto T Kitamura K. A case of confluent and reticulated papillomatosis responsive to roxithromycin (in Japanese). Jap J Clin Dermatol 2001 55 179 182.
7. Ianaro A Ialenti A Maffia P et al. Anti-inflammatory activity of macrolide antibiotics. J Pharmacol Exp Ther 2000 292 156 163.
8. Yatsunami J Tsuruta N Hara N Hayashi S. Inhibition of tumor angiogenesis by roxithromycin, a 14-membered ring macrolide antibiotic. Cancer Lett 1998 131 137 143.
9. Kobayashi M Shimauchi T Hino R Tokura Y. Roxithromycin downmodulates Th2 chemokine production by keratinocytes and chemokine receptor expression on Th2 cells: its dual inhibitory effects on the ligands and the receptors. Cell Immunol 2004 228 27 33.
10. Yatsunami J Fukuno Y Nagata M et al. Antiangiogenic and antitumor effects of 14-membered ring macrolides on mouse B16 melanoma cells. Clin Exp Metastasis 1999 17 361 367.